Comparison of serum albumin, serum c-reactive protein, and pulse wave velocity as predictors of the 4-year mortality of chronic hemodialysis patients

Journal of Atherosclerosis and Thrombosis

Volumn 18, Issue 12, 2011, Pages 1071-1079

  Amemiya, Nobuyuki ^a   Ogawa, Tetsuya ^b   Otsuka, Kuniaki ^b   Ando, Yoshitaka ^c   Nitta, Kosaku ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c Hidaka Hospital   (Japan)

Author keywords

Albumin; All cause mortality; C reactive protein; Hemodialysis; Pulse wave velocity

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PROTEIN BLOOD LEVEL; PULSE WAVE; SURVIVAL; TREATMENT DURATION;

AGED; C-REACTIVE PROTEIN; HUMANS; MIDDLE AGED; MORTALITY; RENAL DIALYSIS; SERUM ALBUMIN;

EID: 84455211571     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.10397     Document Type: Article

References (35)

1. Lowrie EG, Lew NL: Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis, 1990; 15: 458-482
2. Hakim RM, Levin N: Malnutrition in hemodialysis patients. Am J Kidney Dis, 1993; 21: 125-137
3. Kopple JD: Effect of nutrition on morbidity and mortality in maintenance dialysis patients. Am J Kidney Dis, 1994; 24: 1002-1009
4. Yeun JY, Kaysen GA: Factors influencing serum albumin in dialysis patients. Am J Kidney Dis, 1998; 32 (Suppl 4): S118-S125
5. Kaysen GA, Stevenson FT, Depner TA: Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis, 1997; 29; 658-668
6. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int, 1999; 55: 648-658
7. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int, 1999; 55: 1899-1911
8. Beddhu S, Kaysen GA, Yan G, Sarnak M, Agodoa L, Ornt D, Cheng AK for the HEMO Study Group: Association of serum albumin and atherosclerosis in chronic hemodialysis patients. Am J Kidney Dis, 2002; 40: 721-727
9. Daugirdas JT: Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol, 1993; 4: 1205-1213
10. Matsuda N, Takei T, Fujiu A, Ogawa T, Nitta K: Arterial stiffness in patients with non-diabetic chronic kidney disease (CKD). J Atheroscler Thromb, 2009; 16: 57-62
11. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, Koji Y, Hori S, Yamamoto Y: Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res, 2002; 25: 359-364
12. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med, 1998; 15: 539-553
13. Kaysen GA, Dubin JA, Muller HG, Rosales L, Levin NW, Mitch WE; HEMO Group: Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. Kidney Int, 2004; 65: 1408-1415
14. Reuben DB, Ferrucci L, Wallace R, Tracy RP, Corti MC, Heimovitz H, Harris TB: The prognostic value of serum albumin in healthy older persons with low and high serum interleukin-6 (IL-6) levels. J Am Geriatr Soc, 2000; 48: 1404-1407
15. Danielski M, Ikizler TA, McMonagle E, Kane JC, Pupim L, Morrow J, Himmelfarb J: Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis, 2003; 42: 286-294
16. Borawski J, Naumnik B, Pawlak K, Mysliwiec M: Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients associated with pre-dialysis blood pressure and the acute phase response. Nephrol Dial Transplant, 2001; 16: 1442-1447
17. Kaysen GA, Dubin JA, Muller HG, Mitch WE, Rosales LM, Levin NW: Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int, 2002; 61: 2240-2249
18. Yeun JY, Levine RA, Mantadilok V, Kaysen GA: C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis, 2000; 35: 469-476
19. Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierre A, Heimburger O, Lindholm B, Bergstrom J: Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol, 2002; 13 (Suppl 1): S28-S36
20. Honda H, Qureshi AR, Heimburger O, Barany P, Wang K, Pecoits-Fiho R, Stenvinkel P, Lindholm B: Serum albumin, C-reactive protein, interleukin 6, and fetuin A as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis, 2006; 47: 139-148
21. de Mutsert R, Grootendorst DC, Indemans F, Boeschoten EW, Krediet RT, Dekker FW; Netherlands Cooperative Study on the Adequacy of Dialysis-II Study Group: Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr, 2009; 19: 127-135
22. Herselman M, Esau N, Kruger JM, Labadarios D, Moosa MR: Relationship between serum protein and mortality in adults on long-term hemodialysis: echaustive review and meta-analysis. Nutrition, 2010; 26: 10-32
23. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness on survival in endstage renal disease. Circulation, 1999; 99: 2434-2439
24. Shoji T, Emoto M, Shinohara K, Kakiya R, Tsujimoto Y, Kishimoto H, Ishimura E, Tabata T, Nishizawa Y: Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol, 2001; 12: 2117-2124
25. Washida N, Wakino S, Hayashi K, Kuwahara T, Itoh H: Brachial-ankle pulse wave velocity predicts silent cerebrovascular diseases in patients with end-stage renal diseases. J Atheroscler Thromb, 2010; 17: 165-172
26. Virani SS, Polsani VR, Nambi V: Novel markers of inflammation in atherosclerosis. Curr Atheroscler Rep, 2008; 10: 164-170
27. Anan F, Shimomura T, Kaku T, Kaneda K, Imagawa M, Tsukagawa H, Masaki T, Nawata T, Yonemochi H, Eshima N, Saikawa T, Yoshimatsu H: High-sensitivity C-reactive protein level is a significant risk factors for silent cerebral infarction in patients on hemodialysis. Metabolism, 2008; 57: 66-70
28. Stenvinkel P, Andersson P, Wang T, Lindholm B, Bergstrom J, Palmblad J, Heimburger O, Cederholm T: Do ACE-inhibitors suppress tumor necrosis factor-alpha production in advanced chronic renal failure? J Intern Med, 1999; 246: 503-507
29. Chang JW, Yang WS, Min WK, Lee SK, Park JS, Kim SB: Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients. Am J Kidney Dis, 2002; 39: 1213-1217
30. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcorn H Jr, Kopple JD, Greenland S: Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant, 2005; 20: 1880-1888
31. Recio-Mayoral A, Banerjee D, Streather C, Kaski JC: Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease-a cross-sectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis, 2011; 216: 446-451
32. Fiedler R, Jehle PM, Osten B, Dorliqschaw O, Girndt M: Clinical nutrition scores are superior for the prognosis of haemodialysis patients compared to lab markers and bioelectrical impedance. Nephrol Dial Transplant, 2009; 24: 3812-3817
33. Jaar BG, Hermann JA, Furth SL, Briggs W, Power NR: Septicemia in diabetic hemodialysis patients; comparison of incidence, risk factors, and mortality with nondiabetic hemodialysis patients. Am J Kidney Dis, 2000; 35: 282-292
34. KDOQI; National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis, 2006; 47(Suppl): S11-S145
35. Myron Johnson A, Merlini G, Sheldon J, Ichihara K: Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition. Clin Chem Lab Med, 2007; 45: 419-426